Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03428581 · ClinicalTrials.gov registry record · NA
Preventing Lymphedema in Axillary Lymph Node Dissection
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 264
- Enrollment target
NCT03428581: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03428581 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 264 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03428581, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 264 participants
- Enrollment target
Study Summary
The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.
Interventions
- PROCEDURE ALND with ARM +/- LVB
- PROCEDURE ALND
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2018-04-10 |
| Est. Completion | 2025-07-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03428581
The ClinicalTrials.gov registry entry for NCT03428581 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ALND with ARM +/- LVB is the first listed.
NCT03428581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03428581 about?
NCT03428581 is a clinical study titled "Preventing Lymphedema in Axillary Lymph Node Dissection". The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.
What is the current status of trial NCT03428581?
This trial is currently terminated. It is a NA study. The enrollment target is 264 participants. The study started on 2018-04-10. Estimated completion is 2025-07-11.
What interventions are being tested in trial NCT03428581?
The interventions under investigation include: ALND with ARM +/- LVB (PROCEDURE), ALND (PROCEDURE).
Who is sponsoring clinical trial NCT03428581?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.